CK Life Sciences International Holdings (HKSE:00775) Scaled Net Operating Assets : 0.85 (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CK Life Sciences International Holdings's operating assets for the quarter that ended in Dec. 2023 was HK$10,571 Mil. CK Life Sciences International Holdings's operating liabilities for the quarter that ended in Dec. 2023 was HK$1,127 Mil. CK Life Sciences International Holdings's Total Assets for the quarter that ended in Jun. 2023 was HK$11,049 Mil. Therefore, CK Life Sciences International Holdings's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.85.

CK Life Sciences International Holdings Scaled Net Operating Assets Historical Data

The historical data trend for CK Life Sciences International Holdings's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Scaled Net Operating Assets Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.87

0.93

0.82

0.80

0.84

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.83	0.82	0.83	0.85	0.86

Competitive Comparison of CK Life Sciences International Holdings's Scaled Net Operating Assets

For the Biotechnology subindustry, CK Life Sciences International Holdings's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CK Life Sciences International Holdings's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Scaled Net Operating Assets falls into.

CK Life Sciences International Holdings Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CK Life Sciences International Holdings's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(10571.247	-	1127.049)	/	11266.762
=	0.84

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	11247.41	-	676.163
=	10571.247

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7058.157	-	4709.328	-	1221.78
=	1127.049

CK Life Sciences International Holdings's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Dec. 2023 )
=	(Operating Assets (Q: Dec. 2023 )	-	Operating Liabilities (Q: Dec. 2023 ))	/	Total Assets (Q: Jun. 2023 )
=	(10571.247	-	1127.049)	/	11049.28
=	0.85

where

	Operating Assets		(Q: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	11247.41	-	676.163
=	10571.247

	Operating Liabilities		(Q: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7058.157	-	4709.328	-	1221.78
=	1127.049

CK Life Sciences International Holdings Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (HKSE:00775) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

LSI:Germany

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines